Verition Fund Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
101,235
+78,978
+355% +$762K 0.01% 1255
2026
Q1
$165K Sell
22,257
-2,118
-9% -$22.3K ﹤0.01% 1979
2025
Q4
$287K Sell
24,375
-232,637
-91% -$2.51M ﹤0.01% 3025
2025
Q3
$1.98M Buy
257,012
+37,873
+17% +$265K 0.01% 1983
2025
Q2
$1.6M Buy
219,139
+128,174
+141% +$1.03M 0.01% 2114
2025
Q1
$863K Buy
+90,965
New +$1.14M ﹤0.01% 2229
2024
Q4
Sell
-15,510
Closed -$229K 3422
2024
Q3
$229K Buy
+15,510
New +$243K ﹤0.01% 2800
2024
Q2
Sell
-10,170
Closed -$160K 3173
2024
Q1
$160K Buy
+10,170
New +$157K ﹤0.01% 2535
2023
Q4
Sell
-21,225
Closed -$261K 2567
2023
Q3
$261K Buy
+21,225
New +$316K ﹤0.01% 1819
2023
Q2
Sell
-22,295
Closed -$388K 2424
2023
Q1
$388K Buy
+22,295
New +$318K 0.01% 1380
2022
Q4
Sell
-14,450
Closed -$124K 2538
2022
Q3
$124K Buy
+14,450
New +$144K ﹤0.01% 2586
2022
Q2
Sell
-16,053
Closed -$195K 2833
2022
Q1
$195K Buy
+16,053
New +$338K ﹤0.01% 2367
2015
Q2
Sell
-23,650
Closed -$110K 688
2015
Q1
$110K Buy
+23,650
New +$103K 0.01% 343
2014
Q4
Sell
-10,904
Closed -$57K 563
2014
Q3
$57K Buy
+10,904
New +$56K 0.01% 672

Other funds holding NEO

Verition Fund Management's NEO Position: Q2 2026 in Review

Verition Fund Management increased its NeoGenomics (NEO) stake by 355% in Q2 2026, buying an estimated $762K and bringing the position to 101,235 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #1255.

Verition Fund Management first reported a position in NEO in Q3 2014 and has held it in 14 quarters since. The position peaked at $1.98M in Q3 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Verition Fund Management held 101,235 shares of NeoGenomics worth $1.48M as of Q2 2026.
  • Verition Fund Management bought 78,978 NeoGenomics shares in Q2 2026, an estimated $762K.
  • NeoGenomics made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1255 holding.
  • Verition Fund Management first reported a position in NeoGenomics in Q3 2014 and has held it in 14 quarters since.
  • Verition Fund Management's NeoGenomics position peaked at $1.98M in Q3 2025.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.